| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| MRNA | Stock | Healthcare | US$ 58.11 B | 9,41% | |
| TWST | Stock | Healthcare | US$ 12.51 B | 8,00% | |
| TXG | Stock | Healthcare | US$ 12.18 B | 7,28% | |
| ILMN | Stock | Healthcare | US$ 41.23 B | 5,62% | |
| NTRA | Stock | Healthcare | US$ 59.15 B | 5,43% | |
| GH | Stock | Healthcare | US$ 23.86 B | 5,40% | |
Genscript Biotech Corp
|
1548 | Stock | Healthcare | US$ 99.70 B | 4,70% |
| TECH | Stock | Healthcare | US$ 11.36 B | 3,42% | |
| VRTX | Stock | Healthcare | US$ 141.42 B | 3,22% | |
| BMRN | Stock | Healthcare | US$ 11.07 B | 2,99% | |
| QGEN | Stock | Healthcare | US$ 9.24 B | 2,91% | |
| CRSP | Stock | Healthcare | US$ 5.36 B | 2,71% | |
| VCYT | Stock | Healthcare | US$ 3.68 B | 2,48% | |
| BNTX | Stock | Healthcare | US$ 24.34 B | 2,47% | |
|
Caris Life Sciences, Inc. Common Stock
|
CAI | Stock | Healthcare | US$ 8.00 B | 2,46% |
| ARWR | Stock | Healthcare | US$ 9.07 B | 2,42% | |
| PRAX | Stock | Healthcare | US$ 8.25 B | 2,35% | |
| CDNA | Stock | Healthcare | US$ 3.47 B | 2,20% | |
| LEGN | Stock | Healthcare | US$ 3.61 B | 2,06% | |
| LLY | Stock | Healthcare | US$ 1.02 T | 1,74% | |
| BEAM | Stock | Healthcare | US$ 2.53 B | 1,64% | |
| GILD | Stock | Healthcare | US$ 187.51 B | 1,55% | |
|
BillionToOne, Inc. Class A Common Stock
|
BLLN | Stock | Healthcare | US$ 5.00 B | 1,54% |
| WGS | Stock | Healthcare | US$ 2.18 B | 1,32% | |
| SRPT | Stock | Healthcare | US$ 1.85 B | 1,27% | |
| AZN | Stock | Healthcare | US$ 243.34 B | 1,13% | |
| RARE | Stock | Healthcare | US$ 1.50 B | 0,99% | |
| NTLA | Stock | Healthcare | US$ 1.72 B | 0,98% | |
| DHR | Stock | Healthcare | US$ 148.35 B | 0,98% | |
| VIR | Stock | Healthcare | US$ 1.89 B | 0,94% | |
| QURE | Stock | Healthcare | US$ 1.63 B | 0,93% | |
| BMY | Stock | Healthcare | US$ 136.49 B | 0,90% | |
| STOK | Stock | Healthcare | US$ 1.65 B | 0,87% | |
| PSNL | Stock | Healthcare | US$ 1.74 B | 0,80% | |
| MRVI | Stock | Healthcare | US$ 2.93 B | 0,57% | |
| PACB | Stock | Healthcare | US$ 789.51 M | 0,49% | |
| A | Stock | Healthcare | US$ 42.54 B | 0,33% | |
| FLGT | Stock | Healthcare | US$ 591.03 M | 0,31% | |
| BRKR | Stock | Healthcare | US$ 9.64 B | 0,31% | |
| MLAB | Stock | Technology | US$ 741.73 M | 0,27% | |
| MYGN | Stock | Healthcare | US$ 434.25 M | 0,26% | |
| RGNX | Stock | Healthcare | US$ 490.48 M | 0,25% | |
| DGX | Stock | Healthcare | US$ 26.17 B | 0,23% | |
| BNTC | Stock | Healthcare | US$ 313.25 M | 0,23% | |
| PRME | Stock | Healthcare | US$ 540.50 M | 0,20% | |
| RCKT | Stock | Healthcare | US$ 281.02 M | 0,19% | |
| EDIT | Stock | Healthcare | US$ 402.38 M | 0,18% | |
| FLDM | Stock | Healthcare | US$ 286.41 M | 0,16% | |
| CRBU | Stock | Healthcare | US$ 175.82 M | 0,15% |
Average Investor10 user rating
4.0
(1 people)
Global X Genomics & Biotechnology UCITS ETF USD Acc GBP (Ireland) is an exchange-traded fund (ETF), with assets under management totaling $8.06 million.
Over the past 12 months, Global X Genomics & Biotechnology UCITS ETF USD Acc GBP recorded a return of 61.04%, with its price trading between $7.18 and $12.64 during the same period.
The ETF is traded under the ticker GNOG.
The current price of GNOG is $12.03. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
GNOG is currently trading at $12.03, with a market capitalization of approximately $8.060.000,00. Over the past year, the ETF has delivered a 61.04% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in GNOG through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol GNOG, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, GNOG has returned 5.99%, and 61.04% over the past year.
If you were to purchase 100 shares of GNOG at the current price of $12.03, your total investment would be $1,203.00.
After 1 month the profitability would be $1,275.06.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
